Cambium Bio Ltd has released a press release.
FY26 Appendix 4E and Annual Report
Earlier from Cambium Bio
- Cambium Bio Raises A$1.0 Million via Placement
- FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
- Half Year Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report